Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2020
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID studyThomas Lambin, Aurélien Amiot, Carmen Stefanescu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID StudyMathurin Fumery, Benedicte Caron, Xavier Hébuterne, et al.
Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis|November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitisSailish Honap, Joelle St-Pierre, Michael Colwill, et al.
United European Gastroenterology Journal|March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAIDLouis Calméjane, Catherine Reenaers, Claire Gay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Lancet (London, England)|October 16, 2012
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trialDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Inflammatory Bowel Diseases|June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective StudyUri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.
Inflammatory Bowel Diseases|May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European StudyUri Kopylov, Bram Verstockt, Luc Biedermann, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2020
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID studyThomas Lambin, Aurélien Amiot, Carmen Stefanescu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID StudyMathurin Fumery, Benedicte Caron, Xavier Hébuterne, et al.
Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis|November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitisSailish Honap, Joelle St-Pierre, Michael Colwill, et al.
United European Gastroenterology Journal|March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAIDLouis Calméjane, Catherine Reenaers, Claire Gay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Lancet (London, England)|October 16, 2012
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trialDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Inflammatory Bowel Diseases|June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective StudyUri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.
Inflammatory Bowel Diseases|May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European StudyUri Kopylov, Bram Verstockt, Luc Biedermann, et al.
Pageof 26